共 67 条
[1]
Dimopoulos MA(2010)Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group J Clin Oncol 28 4976-4984
[2]
Terpos E(2010)Presentation and survival of patients with severe acute kidney injury and multiple myeloma: A 20-year experience from a single centre Nephrol Dial Transplant 25 419-426
[3]
Chanan-Khan A(2020)Proteosome inhibitor drugs Annu Rev Pharmacol Toxicol 60 457-476
[4]
Leung N(2016)Proteasome inhibitor associated thrombotic microangiopathy Am J Hematol 91 E348-E352
[5]
Ludwig H(2020)Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials Ann Hematol 99 1265-1271
[6]
Jagannath S(2016)Acute Tubular Necrosis in a Patient With Myeloma Treated With Carfilzomib Kidney Int Rep 1 89-92
[7]
Niesvizky R(2020)Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients Blood Cancer J 10 109-undefined
[8]
Giralt S(undefined)undefined undefined undefined undefined-undefined
[9]
Fermand JP(undefined)undefined undefined undefined undefined-undefined
[10]
Blade J(undefined)undefined undefined undefined undefined-undefined